MARCH 2017 | PHARMACEUTICAL PROCESSING
Supply Chain Trends and Transformations
Allen Jacques, VP of Pharma Supply Chain at FusionOps, recently wrote that major transformations are ahead for the
pharmaceutical supply chain. Below are some key drivers and anticipated changes he sees developing in 2017.
• Higher consumer expectations – That, combined
with an increase in scrutiny from
regulators, and an unprecedented
slowdown in mergers and
• The rise of generics – Steadily
increasing and estimated to account
for 91-92% of all prescriptions by
• Increasing prescription volume –
Prompted by an aging population,
new drug introductions, and
• Rise of cold chain logistics –
Fluctuations in demand for
temperature-dependent drugs can
result in exceedingly high inventory
• Marked slowdown in M&A – Life
sciences deal-making fell 65%
behind its previous year rates.
• Digitization – The industry has
begun working in earnest to digitize
the supply chain.
• Push into emerging markets –
Pharmaceutical companies will
continue to ramp-up their efforts
in emerging markets, especially the
BRIC+T regions (Brazil, Russia,
India, China, and Turkey).
• Shift toward global inventory
management – The systems can help
ensure that each region is serviced
with as little overhead as possible.
• Unlocking AI, Big Data and Cloud
technologies – Significant promise
for ROI in supply chain automation
tools. In 2017 these advancements
will continue to evolve toward
making the entire supply chain
The full article by Allen Jacques is available at